Methods of increasing thrombomodulin expression
AssigneeEli Lilly and Company
InventorsDavid S. Calnek, Brian W. Grinnell
Life of this patent
Estimating the term…
Loading patent…
AssigneeEli Lilly and Company
InventorsDavid S. Calnek, Brian W. Grinnell
Estimating the term…
A method of increasing thrombomodulin expression comprising administering to a human in need of treatment an effective amount of a compound having the formula ##STR1## wherein R.sup.1 and R.sup.3 are independently hydrogen, --CH.sub.3, ##STR2## wherein Ar is optionally substituted phenyl; R.sup.2 is selected from the group consisting of pyrrolidino, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof. wherein R.sup.1 and R.sup.3 are independently hydrogen, --CH.sub.3, ##STR3## wherein Ar is optionally substituted phenyl; R.sup.2 is selected from the group consisting of pyrrolidino, hexamethyleneimino, and piperidino; and pharmaceutically acceptable salts and solvates thereof. Also encompassed by the invention is a method of inhibiting a thrombotic disorder or event which includes administering to a human in need thereof an effective amount of a compound of formula 1. Also encompassed by the invention is a method of increasing Protein C activation rate which includes the administration of a compound of formula 1.
A method of increasing thrombomodulin expression comprising administering to a human in need of treatment an effective amount of a compound having the formula ##STR6## wherein R.sup.1 and R.sup.3 are independently hydrogen, --CH.sub.3, ##STR7## wherein Ar is optionally substituted phenyl;
A method for increasing Protein C activation comprising administering to a human in need an effective amount of a compound of the formula ##STR9## wherein R.sup.1 and R.sup.3 are independently hydrogen, --CH.sub.3, ##STR10## wherein Ar is optionally substituted phenyl;
Dependencies are inferred from the claim text.